Bristol-Myers Squibb has tightened rules on the way its sales representatives work with doctors in China after a $14m settlement over bribery allegations.
百时美施贵宝(Bristol-Myers Squibb，简称BMS)收紧了对其销售代表与manbetx3.0 医生打交道方式的规范，此前该公司支付1400万美元了结贿赂指控。
您已阅读8%（232字），剩余92%（2742字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。